Stay updated with breaking news from Sciences Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) have been given an average rating of “Moderate Buy” by the ten research firms that are presently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. […]
Lobe Sciences (TSE:LOBE) has released an update. Lobe Sciences Ltd., a biopharmaceutical company, has announced a change of control after Clearway ...
This newsletter reports on U.S. legal matters relevant to Japanese companies. This edition covers U.S. court cases and cross-border transactions from the winter of 2023-24. Among other things...
Hyaluronic Acid Market by Application (Osteoarthritis, Cosmetics, Pharmaceutical API, Ophthalmology, Others), by End-Use Industry (Personal Care Industry, Pharmaceutical Industry, Others), and by Region (North America, South America, Europe, Asia Pac
Hyaluronic Acid Market by Application (Osteoarthritis, Cosmetics, Pharmaceutical API, Ophthalmology, Others), by End-Use Industry (Personal Care Industry, Pharmaceutical Industry, Others), and by Region (North America, South America, Europe, Asia Pac